Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
SODIUM BENZOATE 10 %-SODIUM PHENYLACETATE 10 % INTRAVENOUS SOLUTION (OTHER RX-40917) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved July 1, 2026 , from http://ppman.hank.ai/transparency/procedure/RX-40917/by-state?code_type=OTHER
“SODIUM BENZOATE 10 %-SODIUM PHENYLACETATE 10 % INTRAVENOUS SOLUTION (OTHER RX-40917) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/RX-40917/by-state?code_type=OTHER. Accessed
July 1, 2026 .
“SODIUM BENZOATE 10 %-SODIUM PHENYLACETATE 10 % INTRAVENOUS SOLUTION (OTHER RX-40917) by State,” HANK Price Transparency ,
accessed July 1, 2026 ,
http://ppman.hank.ai/transparency/procedure/RX-40917/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
OTHER · across United States
RX-40917 — Sodium Benzoate 10 %-sodium Phenylacetate 10 % Intravenous Solution
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$15,284
National median
$4,208 – $30,721
IQR (p25 – p75)
6
hospitals filing
4
states
Walking in without insurance?
Cash / self-pay price
Cash median
$9,045
vs. negotiated
-40.8%
Hospitals reporting
7
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for RX-40917 (OTHER), with interquartile range
State Median p25 p75
LA $59,787 $12,825 $123,284
ID $15,897 $15,509 $16,478
MI $4,252 $3,602 $12,250
IL $2,385 $2,385 $2,385